Strategies

Your ADHD Medication Is Unavailable. Here’s What to Do Right Now.

May 2, 2026 · 8 min read

Last updated September 9, 2026

You called the pharmacy. They are out. You called three more. Same answer. You contacted your prescriber. The alternative is also backordered. Your child has gone days without medication. You are trying to get through your workday without it. This post is for that moment. Here is what is actually happening, why it is not ending quickly, and what you can do right now that is real and evidence-based.

What is happening and why it is not over

The ADHD stimulant shortage began in October 2022 and as of March 2026 remains unresolved. The American Society of Health-System Pharmacists continues to list both immediate-release and extended-release amphetamine mixed salts in active shortage. Adderall, Ritalin, Concerta, and Vyvanse have all been affected at various points, with generic formulations experiencing the most persistent unavailability.

The structural cause is regulatory

Stimulant medications are Schedule II controlled substances, and the DEA sets annual production quotas that cap how much active ingredient manufacturers are legally permitted to produce. The DEA raised production quotas by 25 percent in October 2025 — the first major increase in years — but these adjustments do not immediately translate to more medication on pharmacy shelves. There is no confirmed end date for the shortage.

What going without actually does

This is not a minor inconvenience. Research examining the real-world impact of the shortage found that people with ADHD experienced significant cognitive, emotional, and functional impacts from medication unavailability (Majeed et al., 2025). For children, disrupted medication continuity affects school performance and behavioral regulation quickly. For adults, the impact on work performance, relationship stability, and emotional regulation is equally significant. Going without medication is not a neutral event that can be managed by willpower and patience. It requires active, intentional support. The strategies below are not a replacement for medication. They are a clinical bridge — evidence-based interventions that address the same neurological systems that medication supports, through different mechanisms.

Immediate steps: exhaust the medication options first

Call independent pharmacies first — they often have different supply sources than chains and may have stock when larger retailers do not. This is consistently the most reliable short-term strategy. Use a pharmacy locator tool such as Medfinder to search for pharmacies that currently have your medication in stock without calling every pharmacy individually. Ask your prescriber about alternatives within the stimulant class — multiple medications share similar active ingredients but have better current availability, and switching formulations temporarily, with prescriber guidance, is often more productive than waiting indefinitely. Ask about non-stimulant options as a bridge: atomoxetine and viloxazine are FDA-approved for ADHD and not subject to DEA production quotas. They are not equivalent to stimulants in mechanism or onset, but for some individuals they provide meaningful support during a shortage.

Exercise — start here

This is the highest-priority non-medication intervention available during a shortage and the one most likely to produce noticeable benefit quickly. Aerobic exercise increases dopamine and norepinephrine availability in the prefrontal cortex through the same neurochemical pathways that stimulant medications target (Halperin & Healey, 2011; Ratey & Hagerman, 2008). Research on individuals navigating the shortage specifically identified exercise as one of the most commonly reported coping strategies that provided meaningful benefit (Majeed et al., 2025). The practical recommendation: 20 to 30 minutes of moderate-intensity aerobic activity before the highest-demand period of the day. A single session produces attention-improving effects that can last for hours (Cerrillo-Urbina et al., 2015).

Sleep — stabilize it immediately

Sleep disturbances affect up to 80 percent of adults and children with ADHD. Going without medication often worsens sleep further, creating a compounding cycle: medication unavailability disrupts sleep, disrupted sleep worsens ADHD symptoms, and worsened symptoms make the medication absence feel more severe (Hvolby, 2015). Treat sleep as a clinical intervention: consistent sleep and wake times, a screen-free period of 45 to 60 minutes before bed, and a predictable wind-down routine are among the highest-yield changes available.

Structure and environmental redesign

During a shortage, the ADHD brain is operating with reduced executive support, so external structure must compensate: written schedules rather than mental ones, visual reminders rather than reliance on working memory, and tasks broken into the smallest possible completable units — each completed step produces a dopamine signal that supports continued effort (Volkow et al., 2009). For children, temporarily increase parental scaffolding: more explicit step-by-step guidance, more frequent check-ins, more structured transitions. This is not a regression in expectations — it is an accurate clinical response to temporarily reduced capacity.

Nature exposure

Kuo and Taylor (2004) found that even 20 minutes in a natural setting improved attention in children with ADHD more than equivalent time in urban or indoor environments, with effects consistent across age, gender, and medication status. Natural environments engage effortless, involuntary attention — allowing the directed attentional system that ADHD most depletes to recover (Kaplan, 1995). Scheduled outdoor time during a shortage is a practical, cost-free attentional intervention with real evidence behind it.

Reduce digital access

Without medication, the ADHD brain is significantly more vulnerable to the dopamine-seeking patterns that digital environments exploit. Social media, streaming, and gaming platforms are designed around variable ratio reinforcement schedules — the reward structure that produces the most persistent and difficult-to-interrupt behavior (Swing et al., 2010). During a shortage, unstructured digital access will reliably worsen executive functioning, fragment attention, and disrupt sleep. Reducing screen access — particularly in the morning and the hours before bed — is one of the most immediately protective interventions available.

Protein intake

Dopamine is synthesized from tyrosine, an amino acid found in protein-rich foods including eggs, meat, dairy, fish, and legumes (Fernstrom & Fernstrom, 2007). A breakfast centered around protein rather than refined carbohydrates supports more stable dopamine synthesis across the morning and reduces energy and attention crashes.

A word for parents

The behavioral regression that often follows medication discontinuation is real — and it is neurological, not a choice your child is making. The most clinically important response during a shortage is to reduce demands on your child’s executive functioning while temporarily increasing external scaffolding: shorter homework sessions with movement breaks, more advance warning before transitions, more physical activity before demanding tasks, less screen access, more outdoor time. And when the medication becomes available again — which it will — resist the impulse to immediately return to pre-shortage demands. Many of the structural supports built during the shortage will continue to help after it ends.

The bottom line

The ADHD stimulant shortage is a structural, regulatory problem that has persisted for over three years with no confirmed resolution date. Calling more pharmacies remains the best immediate strategy — along with exploring alternatives with your prescriber’s guidance. Beyond that, the most evidence-supported non-medication bridge is this: exercise before your hardest demands, protect sleep above almost everything else, increase structure in the environment, reduce digital access, go outside, and eat protein at breakfast. The shortage will end. Until then, there is a real clinical path forward.